Luke recently graduated in 2021 with a BSc in Biochemistry from Trinity College Dublin. During his time in the Trinity Biomedical Science Institute he wrote his thesis on the potential for glycol-engineering therapeutic antibodies to increase their effector function and stability. He previously worked as a medical Laboratory technician at Eurofins Biomnis, where he specialised in Immunofixation testing on blood serum samples for the diagnosis of acute myeloid leukemia. Luke joined RCSI in January 2022 working in both the PBS and Surgery Labs, where his role spans the creation of novel in vitro models by 3D bioprinting for colorectal and breast cancers. The breast cancer models will be utilised to explore the influence of non-estrogenic sex steroids in the development of endocrine resistance.